Post-Exposure Prophylaxis (PEP)

This article provides a comprehensive overview of pre-exposure prophylaxis (PrEP), a highly effective HIV prevention medication for people who are HIV-negative and at increased risk of acquiring the virus. It explains that when taken as prescribed, PrEP reduces HIV transmission risk by about 99%, making the chance of contracting HIV from someone correctly using PrEP extremely low.

This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing. 

This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis). 

This issue brief outlines a pharmacist's authority to initiate PrEP & PEP and participate in collaborative practice agreements.

This informational video discusses Post Exposure Prophylaxis (PEP). It includes verbal narration as well as signed American Sign Language.

The goal of this billing and coding guide is to provide up-to-date information and best practices for coding, billing, and denial resolution for PrEP and PEP services. The intention is that this guide will serve as a foundation from which a healthcare organization can build internal PrEP and PEP coding and billing policies. 

Este resumen ofrece un panorama general de la profilaxis de post-exposición (PEP) al virus VIH (virus de inmunodeficiencia humana)

This brief provides an overview of HIV Post-exposure Prophylaxis (PEP) in the southern United States (“the South”). The goal is to provide an overview of prevention with PEP to drive collective action between: Jurisdictional and local public health departments, community-based organizations (CBOs), and community health clinics, to increase and improve prevention with PEP.

This report is an update to the 2009 The National HIV Prevention Inventory: The State of HIV Prevention Across the U.S. (NHPI), which was based on a survey of 65 state, territorial, and local health departments. This report presents findings on HIV prevention programs in the areas of HIV planning, evidence-based interventions, collaboration and integration, implementing the ACA and developing jurisdictional HIV continuums of care. This final module summarizes all activities supported by federal, state, and local HIV prevention funding with a focus on High-Impact Prevention.

This poster is an infographic that presents complex information quickly and clearly about PrEP (Pre-Exposure Prophylaxis), an HIV prevention option that works by taking one pill every day. It is part of CDC's Act Against AIDS, Start Talking. Stop HIV. campaign. The infographic discusses the basics of PrEP and how it works.